Keynote
Living bone grown from a patient's own cells was science fiction a decade ago. Today it is in human trials. Nina shares what it took to get there, from lab bench to FDA-cleared clinical trials: building teams, culture, and conviction for a product that is alive, and the lessons that transfer to anyone building something the world calls impossible.
Growing a living bone for a patient was science fiction when EpiBone started. The product is alive. It has to be grown for each patient, pass the FDA, survive surgery, and outperform titanium — and none of it came with a playbook. Nina has raised $50 million, built a cGMP manufacturing facility, earned first-in-human clearances, and kept a team believing through a decade-long journey from thesis to trials. The lessons translate far beyond biotech.
This talk is for anyone building something the world says is too hard: how to sequence impossible goals into fundable milestones, how to hire for conviction as well as credentials, and how to keep a culture creative under regulatory and financial pressure. Nina's story lands with founders and Fortune 500 teams alike because the constraints differ — the leadership physics don't.
Watch
Proof
Nina Tandon's talk was deeply moving, offering profound insight into the courage and resilience that defines entrepreneurship.
More keynotes
AI is learning the language of cells. Nina maps the convergence of machine intelligence and living systems — from algorithm-designed tissues to biology as the next computing platform — and what it means for every industry that touches the human body.
For
What happens when replacement parts for the human body become real, and they are grown from your own cells? Drawing on the first human trials of lab-grown bone, Nina charts the path from one-size-fits-all healthcare to treatments as personal as a fingerprint, and from living longer to living fully: lifespan, healthspan, and what she calls joyspan.
For
Cells are becoming partners in design: self-healing bridges, living textiles, lab-grown bone and meat. Nina shows how growing products will transform materials, medicine, and supply chains, and what it takes to grow living products safely and at home: the biomanufacturing capacity, the safeguards, and the policy choices behind a secure bioeconomy.
For
Patients research, organize, invest, and demand better. Drawing on a decade of getting EpiBone's first patient to the operating room and the emails that kept arriving, Nina charts how people in pain became partners in medicine: as advocates, as investors through crowdfunding, and as participants claiming the right to try.
For
From TED to Davos, Nina translates the frontier of biology and technology into talks audiences never forget.
Keynotes are booked through The Lavin Agency. Interviews, podcasts, and campus or community talks come straight to Nina's team.